Herpes simplex virus type 1 thymidine kinase-armed bovine herpesvirus type 4-based vector displays enhanced oncolytic properties in immunocompetent orthotopic syngenic mouse and rat glioma models.

Neuro Oncol 2012 Mar 6;14(3):288-301. Epub 2012 Jan 6.

Dipartimento di Salute Animale, Sezione di Malattie Infettive degli Animali, Università di Parma, via del Taglio 8-43126 Parma, Italy.

Gliomas are devastating tumors of the brain resistant to therapies. Although some therapies can prolong the survival time among the affected persons, gliomas are not curable and new therapeutic approaches need to be investigated. Oncolytic viruses seem to represent an interesting alternative, because anticancer agents and new viral agents have to be explored to identify the one with the best characteristics. Bovine herpesvirus type 4 (BoHV-4) is a gammaherpesvirus with a striking tropism and permissive replication toward cancer cells and rat, mouse, and human glioma cells. However, BoHV-4 does not replicate into the normal brain parenchyma. The BoHV-4 genome was cloned as a bacterial artificial chromosome to easily manipulate this large genome and be used as a viral vector platform. In the present study, a herpes simplex virus type 1 thymidine kinase suicide gene-armed BoHV-4 was constructed, characterized, and proven to be highly efficient in killing by apoptosis glioma cells in vitro when co-administered with the pro-drug ganciclovir (GCV). When the armed BoHV-4/GCV therapeutic approach was tested in immunocompetent orthotopic syngenic mouse and rat glioma models in vivo, a significant increase in survival among the treated animals was achieved, and some animals were completely cured. The BoHV-4-based vector represents a promising alternative oncolytic virus for glioma and, perhaps, other types of cancer treatment that merit further investigation. This article represents the result of a mutual interaction between human medical science and veterinary science, a combination of scientific knowledge often neglected.

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nor219DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280804PMC
March 2012
4 Reads

Publication Analysis

Top Keywords

rat glioma
8
herpesvirus type
8
mouse rat
8
syngenic mouse
8
immunocompetent orthotopic
8
orthotopic syngenic
8
glioma models
8
bovine herpesvirus
8
type thymidine
8
virus type
8
simplex virus
8
herpes simplex
8
glioma cells
8
glioma
5
bohv-4/gcv therapeutic
4
gcv armed
4
mouse human
4
permissive replication
4
therapeutic approach
4
replication cancer
4

References

(Supplied by CrossRef)
Malignant gliomas
Burton et al.
Current Treatment Options in Oncology 2000
Epidemiology and etiology of gliomas
Ohgaki et al.
Acta Neuropathologica 2005
Herpesvirus vectors for therapy of brain tumors
Cassady et al.
The Open Virology Journal 2010
The biology of bovine herpesvirus-4 infection of cattle
Thiry et al.
Dtsch Tierarztl Wochenschr 1990
Isolation of a bovine herpesvirus from calves with respiratory disease and keratoconjunctivitis. A preliminary report
Bartha et al.
Acta Veterinaria Academiae Scientiarum Hungaricae 1966
Bovine cytomegaloviruses: identification and differential properties
Storz et al.
The Journal of General Virology 1984

Similar Publications